Enanta Pharmaceuticals
ENTA
#8316
Rank
ยฃ0.23 B
Marketcap
ยฃ8.09
Share price
-2.91%
Change (1 day)
-16.94%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Cash on Hand

Cash on Hand as of June 2026 : ยฃ0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has ยฃ0.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30ยฃ0.14 B-24.28%
2024-09-30ยฃ0.18 B-38.82%
2023-09-30ยฃ0.30 B35.4%
2022-09-30ยฃ0.22 B23.65%
2021-09-30ยฃ0.18 B-39.48%
2020-09-30ยฃ0.29 B9.73%
2019-09-30ยฃ0.27 B15.2%
2018-09-30ยฃ0.23 B41.81%
2017-09-30ยฃ0.16 B3.01%
2016-09-30ยฃ0.16 B68.82%
2015-09-30ยฃ96 M71.51%
2014-09-30ยฃ55.97 M-10.71%
2013-09-30ยฃ62.69 M131%
2012-09-30ยฃ27.13 M81.69%
2011-09-30ยฃ14.93 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ13.06 B 8,991.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ6.80 B 4,636.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.98 B 3,366.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ5.95 B 4,043.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.41 B 3,668.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ9.54 B 6,538.84%๐Ÿ‡บ๐Ÿ‡ธ USA